Finding ways to reduce intracellular the Na+ concentration is a therapeutic route worth considering (Shattock, 2009) and a new target could be a reduction in late Na+ current achieved through inhibition of the cardiac disease dependent Nav1.8. This evidence concerns the gene SCN10A and heart disorder.